World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
220
Citations
361790
World Ranking
136
National Ranking
19

Medicine

D-Index
222
Citations
372914
World Ranking
81
National Ranking
11

Richard Peto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Peto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 866 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Peto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Peto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 222 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2022 - Research.com Medicine in United Kingdom Leader Award
  • 2005 - King Faisal Prize
  • 2004 - Member of the National Academy of Medicine (NAM)
  • 2002 - Charles S. Mott Prize, General Motors Cancer Research Foundation
  • 2000 - Prince Mahidol Award
  • 1992 - Canada Gairdner International Award
  • 1989 - Fellow of the Royal Society, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Richard Peto is affiliated with the University of Oxford in the United Kingdom with a research focus primarily in Medicine.

Their scientific contributions include areas such as:

  • Oncology
  • Infectious Diseases
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Richard Peto's main topics of study cover:

  • Breast Cancer Treatment Studies
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HER2/EGFR in Cancer Research
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Estrogen and related hormone effects

The scientist has published frequently in notable venues, including:

  • The Lancet (4 publications)
  • New England Journal of Medicine (2 publications)
  • Cancer Research (2 publications)
  • The Lancet Oncology (1 publication)
  • The Lancet Gastroenterology & Hepatology (1 publication)

Among the recent papers contributed to by Richard Peto are:

  • "Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results," 2020, New England Journal of Medicine
  • "Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses," 2022, The Lancet
  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials," 2021, The Lancet Oncology
  • "Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy," 2021, The Lancet
  • "Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study," 2020, The Lancet Gastroenterology & Hepatology

Frequently collaborating co-authors include:

  • Hongchao Pan (8 papers)
  • Rosie Bradley (6 papers)
  • Jeremy Braybrooke (6 papers)
  • Robert K. Hills (6 papers)
  • Richard Gray (6 papers)

Richard Peto has been recognized with multiple awards over their career, including:

  • King Faisal Prize, 2005
  • Member of the National Academy of Medicine (NAM), 2004
  • Charles S. Mott Prize, General Motors Cancer Research Foundation, 2002
  • Prince Mahidol Award, 2000
  • Canada Gairdner International Award, 1992
  • Fellow of the Royal Society, United Kingdom, 1989
  • Fellow of The Academy of Medical Sciences, United Kingdom

Best Publications

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

    R C Turner;R R Holman;C A Cull;I M Stratton

  • Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

    Sarah Lewington;Robert Clarke;Nawab Qizilbash;Richard Peto

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

    C Baigent;C Sudlow;R Collins;R Peto

  • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

    C Baigent;A Keech;P M Kearney;L Blackwell

  • The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

    Richard Doll;Richard Peto

  • Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

    R Peto;M C Pike;P Armitage;N E Breslow

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

    C Baigent;L Blackwell;J Emberson

  • COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

    R Altman;L Carreras;R Diaz;E Figueroa

  • Tamoxifen for early breast cancer: An overview of the randomised trials

    M Clarke;R Collins;C Davies

  • Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

    Gary Whitlock;Sarah Lewington;Paul Sherliker

  • Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

    S Macmahon;R Peto;J E Cutler;R Collins

  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

    M Clarke;R Collins;S Darby;C Davies

  • Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context

    R Collins;R Peto;S MacMahon;P Hebert

  • Mortality in relation to smoking: 50 years' observations on male British doctors

    Richard Doll;Richard Peto;Jillian Boreham;Isabelle Sutherland

  • Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

    S Darby;P McGale;C Correa

  • Asymptotically Efficient Rank Invariant Test Procedures

    Richard Peto;Julian Peto

  • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

    Rory Collins;Jane Armitage;Sarah Parish;Peter Sleigh

  • Beta blockade during and after myocardial infarction: an overview of the randomized trials

    Salirn Yusuf;Richard Peto;John Lewis;Rory Collins

  • Risk of Ischemic Heart Disease in Women After Radiotherapy for Breast Cancer

    Sarah C. Darby;Marianne Ewertz;Paul McGale;Anna M. Bennet

Frequent Co-Authors

Rory Collins
Rory Collins University of Oxford
Zhengming Chen
Zhengming Chen University of Oxford
Liming Li
Liming Li Peking University
Richard Doll
Richard Doll University of Oxford
Richard Gray
Richard Gray University of Oxford
Robert Clarke
Robert Clarke University of Oxford
Valerie Beral
Valerie Beral University of Oxford
Jonathan Emberson
Jonathan Emberson University of Oxford
Colin Baigent
Colin Baigent University of Oxford
Peter Sleight
Peter Sleight John Radcliffe Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online pathways within healthcare can accelerate your journey and help you align your education with your career goals. For registered nurses seeking to advance without repeating hands-on training, consider rn to bsn programs without clinicals. These programs allow you to upskill while maintaining a flexible schedule, ideal for working professionals.

If you’re aiming for leadership or advanced clinical roles, pursuing a Doctor of Nursing Practice can be a strategic move. Many students now opt for dnp online programs and specifically seek out dnp online programs designed to be more accessible or quicker to complete, balancing rigorous academics with flexible online learning.

Looking for an entry point into nursing? accelerated lpn program options provide a rapid way into the workforce, allowing students to start their careers and gain valuable experience in less time.

These online degree routes offer flexible solutions for aspiring healthcare professionals, catering to both career changers and experienced nurses aiming to specialize or advance.

Best Scientists Citing Richard Peto

Trending Scientists

Recently Published Articles